Celltrion Pharm, Q3 Operating Profit 13 Billion KRW...122% Increase YoY
[Asia Economy Reporter Kim Heung-soon] Celltrion Pharm announced on the 15th that its operating profit for the third quarter of this year reached 13 billion KRW, an increase of 122.3% compared to the same period last year. Sales during the same period rose 38.8% to 90.9 billion KRW. Accordingly, the cumulative sales and operating profit up to the third quarter of this year were recorded at 275.19 billion KRW and 39.27 billion KRW, respectively. These figures surpass the total annual performance of last year. Celltrion Pharm's sales last year were 235.5 billion KRW, and operating profit was 23.6 billion KRW.
Hot Picks Today
Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- President Lee Appoints Hyun Suyeop as First Vice Minister of Health and Welfare and Lee Jongwook as Commissioner of Korea Customs Service
- "Gave in to the Momentary Temptation": Japanese Police Official Dismissed After Stealing 100 Million Won Next to Body
- "Mom, Isn't It Comfortable Living With Me?"... 'Unexpected Result' Shows Increased Drinking Out of Frustration
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
